Eikon Therapeutics (EIKN) IPO deck
Eikon Therapeutics developed innovative oncology medicines targeting immuno-responsive cancers with high unmet medical need.
Eikon Therapeutics developed innovative oncology medicines targeting immuno-responsive cancers with high unmet medical need.
%20IPO%20deck){kind=link}